title: Evolving treatment landscape in metastatic renal cell carcinoma: where are we now?
authors.affiliation: a Genitourinary Unit, Department of Medical Oncology 1 , Fondazione IRCCS Istituto Nazionale Tumori , Milan , Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Procopio
authors.affiliation: a Genitourinary Unit, Department of Medical Oncology 1 , Fondazione IRCCS Istituto Nazionale Tumori , Milan , Italy.
authors.forename: Raffaele
authors.initials: R
authors.lastname: Ratta
authors.affiliation: a Genitourinary Unit, Department of Medical Oncology 1 , Fondazione IRCCS Istituto Nazionale Tumori , Milan , Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Grassi
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009362:Neoplasm Metastasis; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents